Answers are grounded in this paper and cite their sources.
In hospital-acquired pneumonia (HAP) due to extensively drug resistant gram-negative pathogens, can treatment with high-dose colistin aerosolization using specific aerosol delivery protocol, improve clinical outcome in addition to systemic polymyxin-B?
No takes yet. Share an insight, caveat, or question.
Supradip Ghosh (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: